AU6569990A - Creation of Inventions and Patents with Artificial Intelligence

AU6569990A – Transdermal therapeutic system comprising as active component buprenorphine
– Google Patents

AU6569990A – Transdermal therapeutic system comprising as active component buprenorphine
– Google Patents
Transdermal therapeutic system comprising as active component buprenorphine

Info

Publication number
AU6569990A

AU6569990A
AU65699/90A
AU6569990A
AU6569990A
AU 6569990 A
AU6569990 A
AU 6569990A
AU 65699/90 A
AU65699/90 A
AU 65699/90A
AU 6569990 A
AU6569990 A
AU 6569990A
AU 6569990 A
AU6569990 A
AU 6569990A
Authority
AU
Australia
Prior art keywords
buprenorphine
transdermal therapeutic
therapeutic system
weight
active component
Prior art date
1989-11-29
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Application number
AU65699/90A
Other versions

AU632182B2
(en

Inventor
Lothar Deurer
Thomas Hille
H.-R. Hoffmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

LTS Lohmann Therapie Systeme AG

Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1989-11-29
Filing date
1990-11-01
Publication date
1991-06-06
Family has litigation

First worldwide family litigation filed
litigation
Critical
https://patents.darts-ip.com/?family=6394373&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU6569990(A)
“Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1990-11-01
Application filed by LTS Lohmann Therapie Systeme AG
filed
Critical
LTS Lohmann Therapie Systeme AG

1991-06-06
Publication of AU6569990A
publication
Critical
patent/AU6569990A/en

1992-12-17
Application granted
granted
Critical

1992-12-17
Publication of AU632182B2
publication
Critical
patent/AU632182B2/en

2010-11-01
Anticipated expiration
legal-status
Critical

Status
Expired
legal-status
Critical
Current

Links

Espacenet

Global Dossier

Discuss

Classifications

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K9/00—Medicinal preparations characterised by special physical form

A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug

A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches

A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer

A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds

A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene

A61K9/7061—Polyacrylates

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K31/00—Medicinal preparations containing organic active ingredients

A61K31/33—Heterocyclic compounds

A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins

A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom

A61K31/47—Quinolines; Isoquinolines

A61K31/485—Morphinan derivatives, e.g. morphine, codeine

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K9/00—Medicinal preparations characterised by special physical form

A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

A61P17/00—Drugs for dermatological disorders

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

A61P25/00—Drugs for disorders of the nervous system

A61P25/04—Centrally acting analgesics, e.g. opioids

Abstract

The controlled delivery of buprenorphine or its pharmaceutically compatible salts over at least 24 hours onto the skin is ensured by a transdermal therapeutic system composed of a backing layer which is impermeable to active substance, of an adhesive reservoir layer and, where appropriate, of a protective layer which can be detached again, which system is characterised in that the reservoir layer contains 20-90% by weight of polymeric material, 0.1-30% by weight of plasticiser, 0.1-20% of buprenorphine base or of one of its pharmaceutically acceptable salts and 0.1-30% by weight of solvent for the active substance base.

AU65699/90A
1989-11-29
1990-11-01
Transdermal therapeutic system comprising as active component buprenorphine

Expired

AU632182B2
(en)

Applications Claiming Priority (2)

Application Number
Priority Date
Filing Date
Title

DE3939376A

DE3939376C1
(en)

1989-11-29
1989-11-29

DE3939376

1989-11-29

Publications (2)

Publication Number
Publication Date

AU6569990A
true

AU6569990A
(en)

1991-06-06

AU632182B2

AU632182B2
(en)

1992-12-17

Family
ID=6394373
Family Applications (1)

Application Number
Title
Priority Date
Filing Date

AU65699/90A
Expired

AU632182B2
(en)

1989-11-29
1990-11-01
Transdermal therapeutic system comprising as active component buprenorphine

Country Status (25)

Country
Link

EP
(1)

EP0430019B1
(en)

JP
(1)

JPH0818984B2
(en)

KR
(1)

KR950015061B1
(en)

AT
(1)

ATE135205T1
(en)

AU
(1)

AU632182B2
(en)

CA
(1)

CA2030178C
(en)

CZ
(1)

CZ282557B6
(en)

DE
(2)

DE3939376C1
(en)

DK
(1)

DK0430019T3
(en)

ES
(1)

ES2086353T3
(en)

FI
(1)

FI100379B
(en)

GR
(1)

GR3020177T3
(en)

HR
(1)

HRP930675B1
(en)

HU
(1)

HU206266B
(en)

IE
(1)

IE73247B1
(en)

IL
(1)

IL96243A
(en)

MY
(1)

MY105347A
(en)

NO
(1)

NO303107B1
(en)

NZ
(1)

NZ236191A
(en)

PL
(1)

PL165396B1
(en)

PT
(1)

PT96028B
(en)

SI
(1)

SI9012260B
(en)

SK
(1)

SK279687B6
(en)

YU
(1)

YU47956B
(en)

ZA
(1)

ZA909544B
(en)

Cited By (1)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

AU725245B2
(en)

1997-02-11
2000-10-12
Lts Lohmann Therapie-Systeme Gmbh
Extensible transdermal therapeutic system

Families Citing this family (31)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

US5069909A
(en)

1990-06-20
1991-12-03
Cygnus Therapeutic Systems
Transdermal administration of buprenorphine

US5762952A
(en)

1993-04-27
1998-06-09
Hercon Laboratories Corporation
Transdermal delivery of active drugs

US6344211B1
(en)

1994-12-24
2002-02-05
Lts Lohmann Therapie-Systeme Gmbh
Transdermal absorption of active substances from subcooled melts

DE4446600A1
(en)

1994-12-24
1996-06-27
Lohmann Therapie Syst Lts

Transdermal absorption of active ingredients from supercooled melts

JPH1036265A
(en)

1996-07-19
1998-02-10
Nitto Denko Corp
Buprenorphine percutaneous absorption preparation

US5968547A
(en)

1997-02-24
1999-10-19
Euro-Celtique, S.A.
Method of providing sustained analgesia with buprenorphine

DE19738855C2
(en)

1997-09-05
2001-01-04
Lohmann Therapie Syst Lts

Transdermal therapeutic system with adhesive reservoir layer and unidirectional elastic back layer

DE19828273B4
(en)

1998-06-25
2005-02-24
Lts Lohmann Therapie-Systeme Ag

Transdermal therapeutic system containing hormones and crystallization inhibitors

DE19850517B4
(en)

1998-11-03
2004-02-12
Lts Lohmann Therapie-Systeme Ag

Use of an active substance-containing transdermal therapeutic system in a combined treatment with and without ultrasound

DE19901085C2
(en)

1999-01-14
2003-12-18
Lohmann Therapie Syst Lts

Transdermal therapeutic system with a self-adhesive matrix containing organic acid addition salts of morphine or morphine type alkaloids

DE19923551A1
(en)

1999-05-21
2000-11-30
Lohmann Therapie Syst Lts

Pharmaceutical preparation with the active ingredient diamorphine and its use in a method for treating opiate addiction

DE10056014A1
(en)

2000-11-11
2002-05-16
Beiersdorf Ag
Laminated plaster with active substance, used as transdermal therapeutic system, has impermeable barrier layer on side away from skin and separable carrier layer with adhesive on side towards skin

DE10056012A1
(en)

2000-11-11
2002-05-16
Beiersdorf Ag
Carrier material for medical applications, preferably for transdermal therapeutic system, has aluminum film between carrier and self-adhesive coating

JP4194277B2
(en)

2002-01-25
2008-12-10
久光製薬株式会社

Method for producing pressure-sensitive adhesive molded body mainly composed of crosslinked polymer

DE10237057A1
(en)

2002-08-09
2004-03-25
Grünenthal GmbH
Transdermal therapeutic systems containing buprenorphine, useful in treating pain or urinary incontinence, also containing mu-, kappa- or delta-opioid receptor antagonist to reduce abuse potential

EP1526848B1
(en)

2002-08-09
2007-07-18
Grünenthal GmbH
Opioid-receptor antagonists in transdermal systems having buprenorphine

CA2520613C
(en)

2003-03-31
2012-12-04
Titan Pharmaceuticals, Inc.
Implantable polymeric device for sustained release of dopamine agonist

US8637073B2
(en)

2003-07-25
2014-01-28
Purdue Pharma L.P.
Treatment of dependence withdrawal

DE102004009903A1
(en)

2004-02-26
2005-09-22
Grünenthal GmbH

Patch with reduced skin irritation

EP1743638A1
(en)

2005-07-15
2007-01-17
Laboratorios Del Dr. Esteve, S.A.
Pharmaceutical formulations of substituted pyrazoline compounds

DE102006057083A1
(en)

2005-12-05
2007-06-28
Lg Electronics Inc.

Lighting device for a refrigerator

DE102006054731B4
(en)

2006-11-21
2013-02-28
Lts Lohmann Therapie-Systeme Ag

Transdermal therapeutic system for administration of the active ingredient buprenorphine and use thereof in pain therapy

US9844515B2
(en)

2010-11-17
2017-12-19
Hexal Ag
Transdermal therapeutic system comprising buprenorphine

DE102011076653A1
(en)

2011-05-27
2012-11-29
Acino Ag

Transdermal therapeutic system containing buprenorphine and an alpha hydroxy acid

EP2790685B1
(en)

2011-12-12
2017-08-16
LTS LOHMANN Therapie-Systeme AG
Transdermal delivery system comprising buprenorphine

DE102012000369A1
(en)

2012-01-11
2013-07-11
Alfred E. Tiefenbacher (Gmbh & Co. Kg)

Transdermal therapeutic system with cholinesterase inhibitor

GB2529789A
(en)

2013-06-04
2016-03-02
Lohmann Therapie Syst Lts
Transdermal Delivery system

DE102014013448A1
(en)

2014-09-16
2016-03-17
Alfred E. Tiefenbacher (Gmbh & Co. Kg)

Transdermal therapeutic system comprising buprenorphine

US9656441B2
(en)

2015-01-08
2017-05-23
Alfred E. Tiefenbacher ( Gmbh & Co. Kg)
Transdermal patch

EP3067050A1
(en)

2015-03-13
2016-09-14
Acino AG
Transdermal therapeutic system with an overtape comprising two adhesive layers

CN109045341A
(en)

2018-05-07
2018-12-21
武汉兴嘉业堂医疗科技发展有限公司
A kind of promoting blood circulation and stopping pain pressure sensitive adhesive and preparation method thereof, application

Family Cites Families (10)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

US4464378A
(en)

1981-04-28
1984-08-07
University Of Kentucky Research Foundation
Method of administering narcotic antagonists and analgesics and novel dosage forms containing same

JPS60123417A
(en)

1983-12-07
1985-07-02
Nitto Electric Ind Co Ltd
Drug delivery member

US4626539A
(en)

1984-08-10
1986-12-02
E. I. Dupont De Nemours And Company
Trandermal delivery of opioids

US4806341A
(en)

1985-02-25
1989-02-21
Rutgers, The State University Of New Jersey
Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration

DE3634016A1
(en)

1986-04-17
1987-10-29
Lohmann Gmbh & Co Kg

AREA-BASED THERAPEUTIC SYSTEM, METHOD FOR THE PRODUCTION THEREOF AND ITS USE

JPS632533A
(en)

1986-06-23
1988-01-07
Yamakawa Sangyo Kk
Molded sand for precision casting

CH672888A5
(en)

1986-11-07
1990-01-15
Mepha Ag

DE3862405D1
(en)

1987-03-09
1991-05-23
Alza Corp

COMPOSITION FOR PREVENTING CONTACT ALLERGY BY SIMULTANEOUSLY ADMINISTERING A CORTICOSTEROID WITH A SENSITIZING MEDICINAL PRODUCT.

EP0375689B1
(en)

1987-06-01
1992-08-12
Warner-Lambert Company
A pharmaceutical composition adapted for transdermal delivery of an opoid drug.

DE3843237A1
(en)

1988-12-22
1990-07-05
Lohmann Therapie Syst Lts

TRANSDERMAL THERAPEUTIC SYSTEM WITH AN ANTIADIPOSITUM AS AN ACTIVE INGREDIENT

1989

1989-11-29
DE
DE3939376A
patent/DE3939376C1/de
not_active
Expired – Lifetime

1990

1990-11-01
AU
AU65699/90A
patent/AU632182B2/en
not_active
Expired

1990-11-05
IL
IL9624390A
patent/IL96243A/en
not_active
IP Right Cessation

1990-11-05
MY
MYPI90001939A
patent/MY105347A/en
unknown

1990-11-13
CZ
CS905598A
patent/CZ282557B6/en
not_active
IP Right Cessation

1990-11-13
SK
SK5598-90A
patent/SK279687B6/en
not_active
IP Right Cessation

1990-11-16
CA
CA002030178A
patent/CA2030178C/en
not_active
Expired – Lifetime

1990-11-20
DE
DE59010192T
patent/DE59010192D1/en
not_active
Expired – Lifetime

1990-11-20
JP
JP2312968A
patent/JPH0818984B2/en
not_active
Expired – Lifetime

1990-11-20
EP
EP90122120A
patent/EP0430019B1/en
not_active
Expired – Lifetime

1990-11-20
DK
DK90122120.0T
patent/DK0430019T3/en
active

1990-11-20
AT
AT90122120T
patent/ATE135205T1/en
not_active
IP Right Cessation

1990-11-20
ES
ES90122120T
patent/ES2086353T3/en
not_active
Expired – Lifetime

1990-11-22
NZ
NZ236191A
patent/NZ236191A/en
unknown

1990-11-26
NO
NO905103A
patent/NO303107B1/en
not_active
IP Right Cessation

1990-11-27
YU
YU226090A
patent/YU47956B/en
unknown

1990-11-27
SI
SI9012260A
patent/SI9012260B/en
unknown

1990-11-28
HU
HU907677A
patent/HU206266B/en
unknown

1990-11-28
PT
PT96028A
patent/PT96028B/en
not_active
IP Right Cessation

1990-11-28
KR
KR1019900019329A
patent/KR950015061B1/en
not_active
IP Right Cessation

1990-11-28
ZA
ZA909544A
patent/ZA909544B/en
unknown

1990-11-28
IE
IE429090A
patent/IE73247B1/en
not_active
IP Right Cessation

1990-11-28
PL
PL90287989A
patent/PL165396B1/en
unknown

1990-11-29
FI
FI905892A
patent/FI100379B/en
active
IP Right Grant

1993

1993-04-01
HR
HRP-2260/90A
patent/HRP930675B1/en
not_active
IP Right Cessation

1996

1996-06-06
GR
GR960401538T
patent/GR3020177T3/en
unknown

Cited By (1)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

AU725245B2
(en)

1997-02-11
2000-10-12
Lts Lohmann Therapie-Systeme Gmbh
Extensible transdermal therapeutic system

Also Published As

Publication number
Publication date

FI100379B
(en)

1997-11-28

FI905892A0
(en)

1990-11-29

PT96028A
(en)

1991-09-13

CA2030178C
(en)

1995-08-15

IL96243A0
(en)

1991-08-16

KR950015061B1
(en)

1995-12-21

ZA909544B
(en)

1992-08-26

CZ282557B6
(en)

1997-08-13

PL287989A1
(en)

1991-09-09

IE73247B1
(en)

1997-05-21

HRP930675A2
(en)

1994-10-31

ES2086353T3
(en)

1996-07-01

DK0430019T3
(en)

1996-07-22

NO905103D0
(en)

1990-11-26

JPH0818984B2
(en)

1996-02-28

YU226090A
(en)

1992-12-21

PL165396B1
(en)

1994-12-30

HU206266B
(en)

1992-10-28

EP0430019B1
(en)

1996-03-13

SI9012260B
(en)

1998-06-30

CA2030178A1
(en)

1991-05-30

NO905103L
(en)

1991-05-30

SK279687B6
(en)

1999-02-11

KR910009249A
(en)

1991-06-28

DE3939376C1
(en)

1991-05-08

EP0430019A3
(en)

1991-09-18

JPH03193732A
(en)

1991-08-23

ATE135205T1
(en)

1996-03-15

SI9012260A
(en)

1997-10-31

GR3020177T3
(en)

1996-09-30

FI905892A
(en)

1991-05-30

AU632182B2
(en)

1992-12-17

PT96028B
(en)

1998-02-27

NO303107B1
(en)

1998-06-02

HUT55643A
(en)

1991-06-28

HRP930675B1
(en)

1999-10-31

NZ236191A
(en)

1993-05-26

MY105347A
(en)

1994-09-30

DE59010192D1
(en)

1996-04-18

CS9005598A2
(en)

1991-12-17

IL96243A
(en)

1994-11-28

IE904290A1
(en)

1991-06-05

EP0430019A2
(en)

1991-06-05

YU47956B
(en)

1996-07-24

Contact information